Latest Headlines
-
Verdot Expands Offering With FlexiPro TFF System To Meet Growing Industry Demand
9/18/2023
Leading downstream bioprocessing technology company, Verdot, announces the launch of its FlexiPro TFF, a multipurpose tangential flow filtration (TFF) GMP system, in response to rising industry demand for gene therapy, vaccine, and mRNA-based therapeutics.
-
Qosina Adds OneShot™ Single-Use Filling Needles From Overlook Industries To Its Bioprocess Components Portfolio
8/24/2023
Qosina, a global supplier of OEM single-use components to the medical and biopharmaceutical industries, is pleased to introduce OneShot™ single-use filling needles from Overlook Industries, a manufacturer of single-use filling needles and molded fluid path assemblies for pharma and biopharma fill-finish machinery.
-
Relive Synthego’s New GMP Facility Inauguration Celebration
8/17/2023
The grand opening of Synthego’s new GMP facility was inaugurated with speeches from iconic figures in the gene editing space followed by a ribbon-cutting celebration. In this blog, you can relive this remarkable event.
-
Milan Cell And Gene Therapy Development And Manufacturing Site Expansion
8/9/2023
The completed expansion of the Milan Cell & Gene Center of Excellence production site added 1 x 50L, 2 x 200L and 2x 1,000L suspension single-use bioreactors.
-
Advancing Patient Access To CAR-T Therapies
8/8/2023
Cardinal Health has begun the longest RWE follow-up study on patients receiving CAR-T therapy for relapsed or refractory multiple myeloma, giving better insight into the effectiveness and safety of CAR-T products.
-
BioCentriq Selected To Present Its Capabilities At Meeting On The Mesa
8/2/2023
Organized by the Alliance for Regenerative Medicine, the Cell & Gene Meeting on the Mesa is a three-day conference that addresses the commercialization challenges of today’s cell and gene therapy industry.
-
New Cell Therapy CDMO Kincell Bio To Develop In-House Manufacturing Capacity
7/26/2023
Kincell Bio, a technology-forward contract development and manufacturing organization (CDMO) focused on cell therapies, today emerged from stealth with $36 million in new funding. Kineticos Ventures led Kincell’s launch funding.
-
CDMO Biovian Announces Significant Investment Into Drug Manufacturing Facility In Finland
7/26/2023
Biovian Oy, a leading contract development and manufacturing organization (CDMO) specializing in biopharmaceuticals, announces a major investment of over €50 million to expand its manufacturing facility in Turku, Finland.
-
Qosina Introduces Aramus™ 2D Bag Chambers From Entegris To Its Bioprocess Components Portfolio
7/20/2023
Qosina is pleased to announce the addition of Aramus 2D bag chambers from Entegris.
-
Entegris And Agilitech: Transforming Single-Use Technologies
7/19/2023
Entegris announces their collaboration with Agilitech, allowing them to offer an extended line of custom, single-use systems for cell and gene therapies.